Full Press Release Details
Immutep’s Chinese Partner EOC Pharma to Start Phase II Metastatic Breast Cancer Study.
IMMP
Immutep’s Chinese Partner EOC Pharma to Start Phase II Metastatic Breast Cancer Study
Key Takeaway: Immutep’s Chinese Partner EOC Pharma to Start Phase II Metastatic Breast Cancer Study